Home > Category > Signaling Pathways > Antibody-drug Conjugate/ADC Related > Drug-Linker Conjugates for ADC > Cantuzumab

Cantuzumab

Catalog No：CLA1065 CAS No.：400010-39-1 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$1600.00	Visible after login	- +
5 mg	3-5days	$4300.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Cantuzumab
CAS	400010-39-1
Storage condition	Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles

Product details

Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1065

Cantuzumab

400010-39-1 95+%